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Abstract
Background: In the USA, stillbirth (in utero fetal death ≥20 weeks gestation) is a major public health issue. Women
who experience stillbirth, compared to women with live birth, have a nearly sevenfold increased risk of a positive
screen for post-traumatic stress disorder (PTSD) and a fourfold increased risk of depressive symptoms. Because the
majority of women who have experienced the death of their baby become pregnant within 12–18 months and the
lack of intervention studies conducted within this population, novel approaches targeting physical and mental
health, specific to the needs of this population, are critical. Evidence suggests that yoga is efficacious, safe,
acceptable, and cost-effective for improving mental health in a variety of populations, including pregnant and
postpartum women. To date, there are no known studies examining online-streaming yoga as a strategy to help
mothers cope with PTSD symptoms after stillbirth.
Methods: The present study is a two-phase randomized controlled trial. Phase 1 will involve (1) an iterative
design process to develop the online yoga prescription for phase 2 and (2) qualitative interviews to identify
cultural barriers to recruitment in non-Caucasian women (i.e., predominately Hispanic and/or African American)
who have experienced stillbirth (N = 5). Phase 2 is a three-group randomized feasibility trial with assessments
at baseline, and at 12 and 20 weeks post-intervention. Ninety women who have experienced a stillbirth
within 6 weeks to 24 months will be randomized into one of the following three arms for 12 weeks: (1)
intervention low dose (LD) = 60 min/week online-streaming yoga (n = 30), (2) intervention moderate dose
(MD) = 150 min/week online-streaming yoga (n = 30), or (3) stretch and tone control (STC) group = 60 min/
week of stretching/toning exercises (n = 30).
Discussion: This study will explore the feasibility and acceptability of a 12-week, home-based, online-streamed
yoga intervention, with varying doses among mothers after a stillbirth. If feasible, the findings from this study
will inform a full-scale trial to determine the effectiveness of home-based online-streamed yoga to improve
PTSD. Long-term, health care providers could use online yoga as a non-pharmaceutical, inexpensive resource
for stillbirth aftercare.
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Background
In the USA, the death of a baby to stillbirth (in utero
fetal death ≥20 weeks gestation) is a major public health
issue. Each year more than 26,000 babies are stillborn,
and in many cases, even after a postmortem evaluation,
the cause is unknown [1]. Many mothers suppress their
grief and feel stigmatized, socially isolated, and their
baby’s lives devalued by society [2]. These experiences
seem to worsen trauma reactions, such as despair,
thoughts of suicide, anxiety, guilt, shame, and anger [3–5].
Symptoms can last up to 18 years [6–8] and are likely to
re-occur in subsequent pregnancies [9, 10]. In an effort to
destigmatize stillbirth,The Lancet has published two issues
dedicated entirely to stillbirth in 2011 and 2016 [11, 12].
Psychological health
Women who experience stillbirth, compared to women
with live birth, have a nearly sevenfold increased risk of
a positive screen for post-traumatic stress disorder
(PTSD), a fourfold increased risk of depressive symp-
toms, twice the risk of a positive screen for generalized
anxiety disorder [13, 14]. Symptoms of PTSD and its as-
sociated comorbidities (e.g., anxiety and depression) may
contribute to diminished self-compassion (i.e., poor self
care), emotional dysregulation, and compromised sleep
quality, all of which have been associated with declining
physiological well-being, weight retention/gain, increased
chronic disease risk (e.g., heart disease, diabetes), prema-
ture mortality, poor quality of life, and cognitive delays in
subsequent children [15–17]. Because the majority of
women who have experienced the death of their baby
become pregnant within 12–18 months [18], novel ap-
proaches targeting physical and mental health, specific to
the needs of this population, are critical.
Interventions
A recent Cochrane review [19] demonstrates the need
for clinical trials to assess interventions to support
women after the loss of a baby to stillbirth. A recent
systematic review [20] evaluated intervention studies in
bereaved mothers after stillbirth and identified only two
[one small RCT and one feasibility study (outside of
US)] from 1980 to 2015. One RCT evaluated a support
group in women after a stillbirth compared to a no-
treatment concurrent control group. The authors
concluded that grief counseling may reduce grief symp-
tomology after a stillbirth. This is particularly salient in
mothers with poor social support [21]. The other ex-
plored the feasibility, acceptance, and cultural fit of a
brief mindfulness-based intervention to reduce perinatal
grief and other mental health indices (i.e., depression,
coping) among Indian mothers [22]. There were signifi-
cant improvements in anxiety, depression, coping, life
satisfaction, social provisions, and mindfulness as a re-
sult of the intervention.
Given the lack of intervention studies conducted within
this population, more research with appropriate control
groups are needed to inform evidence-based care.
Rationale for study
The most common treatments for PTSD are exposure
therapy [23], eye movement desensitization and reproces-
sing (EMDR) [24], referral to support groups/interper-
sonal counseling [25, 26], and/or psychiatric medication
or other medications to treat physical symptoms [27].
Although these strategies demonstrate some effectiveness
in the general population with PTSD, they are unlikely to
be fully effective for bereaved mothers for a variety of rea-
sons. First, bereaved mothers’ engagement in treatment
(e.g., initiation of therapy, support groups) is uncommon
(<25%) [13]. Second, because bereaved mothers may be
trying to conceive again, or have already conceived, they
are often reluctant to take psychiatric medication, prefer-
ring non-pharmacologic alternatives [1]. In addition,
medication cannot address the psychosocial aspects of
grief and the accompanying emotional distress [28]. Third,
though support groups for bereaved parents may provide
a familiar and safe environment to connect with others
who have had similar experiences [29, 30], these groups
often have little to no emphasis on adaptive coping strat-
egies for PTSD symptoms (e.g., hypervigilance, intrusion,
avoidance) and the underlying emotional etiology [19, 31].
Fourth, bereaved mothers report unique barriers to par-
ticipation in activities outside the home, such as encoun-
tering other babies in public, and many express strong
interest in home-based treatments [32]. Finally, women
may not have access to specialized treatment (e.g., expos-
ure therapy, support groups) based on where they live,
insurance coverage, or access to specialized clinicians,
resulting in limited options for treatment [30, 33, 34]. It is
crucial for science to develop novel approaches to inter-
conception care amenable to the needs of these mothers.
Yoga may be an ideal treatment for addressing the
unique PTSD symptoms of bereaved mothers after the
death of a baby. Several studies have demonstrated that
yoga is efficacious, safe, acceptable, and cost-effective for
improving mental health in a variety of populations, in-
cluding pregnant and postpartum women [35–41]. Yoga
has also been used as a means to cope with PTSD symp-
toms after traumatic events (e.g., interpersonal violence,
war, natural disasters) [42–45]. To date, there are no
known studies examining yoga as a strategy to help
bereaved mothers cope with PTSD symptoms after
stillbirth.
This manuscript will describe a study protocol for a
three-group randomized feasibility trial in US-based
mothers and follows the reporting guidelines outlined by
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the SPIRIT checklist [46]. This study has the following
objectives:
1. Examine the feasibility and acceptability of a 12-week,
home-based, online-streamed yoga intervention, with
varying doses (low = 60 min/week; moderate =
150 min/week) among bereaved mothers who have
experienced the death of a baby to stillbirth. Feasibility
is defined as acceptability, demand, and practicality
(see the “Outcome measures” section for operational
definitions).
2. Adapt an already established, evidence-based control
group [47–50] and determine its acceptability for a
future randomized controlled trial. Adaptation is
defined as age- and population-specific. Acceptability
is defined as adherence and satisfaction.
3. Ascertain the preliminary effects of the intervention
on reducing PTSD symptoms below the clinical
threshold.
4. Explore potential mechanisms (i.e., self-compassion,
emotional regulation, sleep disturbance) by which
yoga may reduce PTSD symptoms in bereaved
versus non-bereaved mothers. We will also
determine intervention effects on co-morbid
conditions such as anxiety and depression.
Methods/design
Study design
The study will occur within two phases—one for the for-
mative work to inform the intervention and another to
implement the intervention (see Fig. 1 for a flow chart
of study phases).
Phase 1
Part A. Iterative design: We will develop the yoga
prescription using an iterative design process with the
following steps:
1. Identify 30 videos from the existing UDAYA (an
online-streaming commercial yoga website;
https://udaya.com) library.
2. Gather a panel of women whose babies were
stillborn (n = 5) and a panel of women who are
regular yoga practitioners and have not
experienced a baby’s death (n = 5) to review (i.e.,
watch or engage) yoga videos selected from step
one above.
3. Develop (produced by Udaya.com) up to 12, 30-min
yoga videos specifically for the grieving mothers.
Part B. Interviews to identify cultural barriers to
recruitment: We will recruit five non-Caucasian
(predominately Hispanic and/or African American)
women who have experienced stillbirth to participate
in a 15–20 min phone interview. These interviews
will guide the recruitment process for phase 2, and
additional recruitment materials will be developed to
ensure adequate enrollment of non-Caucasian women
in the study. The interview questions will consist of
questions related to:
1. Perceptions/opinions about yoga related to physical
and mental health.
2. Strategies to ensure adequate enrollment and
retention of non-Caucasian women to participate in
a yoga intervention.
Fig. 1 Study flow chart: the left side of the diagram illustrates the flow of the study for phase 1, and the right side illustrates the phase 2
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Phase 2
Phase 2 is a three-group randomized feasibility trial with
assessments at baseline and at 12 and 20 weeks from
baseline. After completion of the consent process and
the baseline assessment, 90 women will be randomized
into one of the following three arms for 12 weeks: (1)
intervention low dose (LD) = 60 min/week yoga (n = 30),
(2) intervention moderate dose (MD) = 150 min/week yoga
(n = 30), or (3) stretch and tone control (STC) group =
60 min/week of stretching/toning exercises (n = 30).
Eligibility criteria
Inclusion and exclusion criteria for phase 1 (iterative de-
sign and interviews) are described in Table 1, and those
for phase 2 are described in Table 2.
Interventions
Phase 1
Iterative design Women (N = 10) will be asked to come
to the Healthy Lifestyles Research Lab at a University in
the Southwestern United States for nine sessions (i.e.,
20–60 min). Thirty online yoga videos from Udaya’s li-
brary, preselected by a yoga therapist and the principal
investigator, will be randomly assigned (using a random
number table) to participants. Each participant will be
randomly assigned nine different online yoga videos so
that each video is reviewed at least three times. Selection
criteria for the 30 online yoga videos include the follow-
ing: (1) have been used in our previous beta-testing [51]
and were positively reviewed by mothers bereaved by
stillbirth, (2) videos that the research team believes will
cultivate emotional regulation and self-compassion (evi-
dence-based proposed mediators from a general popula-
tion with PTSD), (3) classes that are slower moving (i.e.,
beginner-based) with detailed instruction and alignment
cues (i.e., safe and proper form), and (4) classes that are
safe for women up to 20 weeks gestation in case a
woman becomes pregnant during the intervention. Each
woman will be asked to watch/engage in the yoga video
by herself in an observation room. Participants will not
be able to review more than one video per day to limit in-
fluence from another video. Before and after engaging in
the yoga videos, women will be asked two investigator-
developed questions related to the potential mechanisms
by which yoga may reduce PTSD symptoms, including
self-compassion [How much self-compassion do you feel
(i.e., self-kindness, understanding toward yourself and
your grief, common humanity, mindfulness) right now?]
and emotional regulation [How much do you feel that you
are able to be with your emotions (i.e., consciously stay
with your emotions or mood) right now?]. Questions will
be answered on a five-point Likert scale. Mean scores will
Table 1 Phase 1 eligibility criteria
Inclusion
Iterative design
• Able to read/understand/speak English
• Women who experienced stillbirth within past 6 weeks to
24 months OR
• Women who have not experienced stillbirth but have given at least
one live birth who regularly practice yoga (participate in yoga
>60 min/week)
Interviews
• Able to read/understand/speak English
• Racial/ethnic minority women
• Women who experienced stillbirth within past 6 weeks to
24 months
• Not regularly practicing yoga (participating in yoga <60 min/week)
• Underactive (≤120 min/week moderate-intensity physical activity)
Exclusion
Iterative design
• Women who have experienced stillbirth that regularly practice yoga
(i.e., ≥60 min/week)
• Pregnant women
• Unstable psychiatric condition (psychosis; suicidal ideation with plan)
Interviews
• Caucasian women
• Unstable psychiatric condition (psychosis; suicidal ideation with plan)
Table 2 Phase 2 eligibility criteria
Inclusion
• Women who experienced stillbirth within past 6 weeks to
24 months
• Clinical levels posttraumatic stress symptoms (score of ≥33 on IES)
• ≥18 years of age
• Residing in the USA
• Able to read/understand/speak English
• Underactive (≤120 min/week moderate-intensity physical activity)
• Willing to be randomized
• Regular internet access via mobile phone, desktop/laptop computer,
tablet, and etc.
• Answer “no” to all items on the PAR-Q (can participate safely)
Exclusion
• Unstable psychiatric condition (psychosis; suicidal ideation with plan)
• Pregnant at time of enrollmenta
• Practicing yoga at least 60 min/week
• Unwilling to be randomized to a group
• Score of 20–27 of PHQ-9 (severe depression score)
• At risk for suicide based on follow-up phone assessment by Dr.
Cacciatore after positive screen (PHQ-9 score of 1, 2, or 3)
aPregnant women will not be eligible for initial recruitment into the study.
Women who become pregnant during the study will complete a PARmed-X
for Pregnancy with their physician to identify any contraindications to yoga
and will be able to continue participation
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be taken for each video and entered into an Excel docu-
ment. Those videos that elicit the highest self-compassion
and/or emotional regulation will be used for phase 2.
Interviews
One research staff member trained by an expert in quali-
tative research will conduct the interviews using a semi-
structured interview guide. All interviews (N = 5) will be
recorded and transcribed verbatim. The insight provided
from the interviews will be used to modify the recruit-
ment materials for phase 2 as needed.
Phase 2
The online videos prescribed in all three conditions will
be suitable for women up to 20 weeks gestation (the
maximum possible based on our study eligibility) in the
case that a participant becomes pregnant during the
study. Additionally, a nationally certified instructor (i.e.,
yoga or fitness) will teach the online videos.
Low and moderate dose intervention groups The low
and moderate dose intervention groups will be asked to
follow a 12-week online yoga prescription (for 60 and
150 min/week, respectively). We selected the low dose
of 60 min/week because this is the minimal amount
needed to experience mental and/or physical health ben-
efits [40, 52–55]. We chose the moderate dose of
150 min/week because this reflects the physical activity
guidelines [56].
The style of the online yoga videos will be Hatha be-
cause (1) Hatha combines a physical practice with a
meditative component to cultivate mindfulness (i.e., mo-
ment to moment, non-judgmental awareness, cultivated
by paying attention in a specific way) [57] and self-
awareness and (2) includes instruction from a variety of
lineages (e.g., Iyengar, Asthanga, Vinyasa). The online
prescription assures the poses used are identical for both
intervention groups. Participants will be asked to
complete the yoga videos in a specific order, which will
include specialized preparatory instructions for each
video to ensure comfort and safety [56].
Stretch and tone control group The STC group will be
asked to follow a 12-week online stretching/toning exer-
cise prescription for 60 min/week to match minimal
dose of intervention group (i.e., LD). We will develop
12, 30-min videos for the STC group prescription (pro-
duced and filmed by UDAYA). The STC videos will be
adapted from an already existing, well-established,
evidence-based control condition (originally designed for
older adults in other funded trials) to be specific for
women who are underactive (<150 min of moderate activ-
ity per week) [47–49, 58, 59]. The instructor will begin
and end each class with a 3-min warm-up/cooldown. The
instructor will ask participants to perform each isolated
stretch or toning exercise for 1–2 sets (20–45 s or between
10 and 15 repetitions). Participants will be asked to per-
form slow, controlled, and complete movements. Pro-
gression will include demonstration by the instructor of
modifications with a slightly less difficult and a more
challenging version for the specific exercise. For ex-
ample, a participant may be asked to perform a plank
on their knees and a modification may be to straighten
their legs, making the exercise more difficult. Variabil-
ity will be demonstrated by changing the stretching and
toning exercises every 3 weeks. For example, in the first
3 weeks, participants will be introduced to the new ac-
tivities, and in the remaining weeks 4 to 12, they are
encouraged to increase the difficulty by adding more
repetition or performing the more challenging modifi-
cation. Participants will be asked to complete the STC
videos in a specific order, which will include a warm-
up, four upper body, four lower body, three trunk/core,
and one to two balance exercises, with appropriate pro-
gression over 12 weeks. The STC videos will have discus-
sion related to form and safety by the instructor (i.e., no
guidance for movement with breath or mindfulness).
Additionally, videos will have students in the background
following instructor cues and demonstrating variations of
exercises. There will be no final relaxation pose in the
STC videos (i.e., the rest period after completion of a yoga
class).
Procedures UDAYA will provide the research team with
90 membership accounts pre-paid for the length of the
study that will have access only to the videos specific to
the participants group assignment (i.e., participants will
not have access to the full UDAYA video library). The
research staff will assign UDAYA membership accounts
to all participants (i.e., intervention and control) upon
enrollment into the study and will provide them with a
username and password to access UDAYA prior to their
participation in the study. In addition, participants will
be asked to wear an accelerometer (i.e., GENEActiv) to
measure physical activity and sleep quality for 1 week at
baseline, post-intervention (12 weeks from baseline), and
follow-up (20 weeks from baseline) and complete assess-
ments at these time points.
Participation in the videos (intervention and control
groups) will be automatically tracked (class taken, time
of day, length of use, and etc.) via web analytics software
throughout the study in each group. Research personnel
will send weekly reminders (email or text message) to
participants for minimal dose compliance. Additionally,
the research team will send each participant a Qualtrics
link to report (1) completion of sessions, (2) rating of
perceived exertion, (3) assessment of mindfulness, (4)
other physical activity participation, (5) pregnancy status,
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mental health, use of psychiatric medication, and adverse
events. Participants will be asked weekly about participation
in support groups or individual/group-based counseling
sessions. Participants will be discouraged from attending
face-to-face yoga/stretching/toning classes during the
study.
In the case that a woman becomes pregnant during
the study, she will be asked to complete the Physical Ac-
tivity Readiness Medical Examination for Pregnancy
(PARmed-X for Pregnancy), a health screening tool com-
pleted with the health care provider to ensure it is safe
for women to participate in prenatal exercise. We will
also send women a pregnancy safety handout (specific to
yoga or general physical activity depending on group as-
signment) for their review.
The study will be stopped prior to its completion
based upon (1) clinical deterioration of PTSD sympto-
mology (increased scores of >20 points from baseline on
the Impact of Event Scale-Revised (IES-R) in >50% of
the enrolled participants), (2) difficulty in study recruit-
ment (i.e., at halfway through the timeline of recruit-
ment, study recruitment falls below 30% of the total
recruitment goal), and (3) if any new safety information




Table 3 outlines the outcome measures and associated
time points.
Feasibility (acceptability, demand, and practicality)
We will utilize Bowen and colleagues’ [60] standards for
feasibility studies. Acceptability measures include satis-
faction with the online-streamed yoga intervention,
perceived appropriateness of the intervention for this
population, and intent to continue using intervention
materials and will be assessed via satisfaction survey at
post-intervention. Demand, including expressed interest
in participating in study and actual use of intervention,
will be measured via Udaya.com online tracking (i.e., #
times logged in, time spent in class, completion of class,
date/time of class access) and daily logs (i.e., yoga
sessions, Borg Rating of Perceived Exertion Scale, and
Meditative Movement Inventory). Practicality measures,
including the ability of participants to carry out inter-
vention activities (i.e., yoga), will be assessed via the
Udaya.com tracking system, weekly logs, and satisfaction
survey at the end of the intervention. Qualitative inter-
views following best practices for conducting interviews,
including developing a priori questions and written
moderator protocol and recording and transcribing data
[61, 62], will be used to supplement information gained
from the satisfaction surveys and to further understand
the use of non-pharmacological interventions such as yoga
in this population. Qualitative interviews will be adminis-
tered in the intervention groups at post-intervention
(12 weeks) and at follow-up (20 weeks).
For the intervention group(s), our benchmarks will be
as follows: (1) feasibility (i.e., satisfaction, useful, appro-
priate, acceptable ≥70%, (2) demand (i.e., recommend to
others, continue to use skills, program easy to complete
Table 3 Summary of data collection
Baseline 12 weeks 20 weeks
Demographics X





Udaya.com tracking system X X
Daily log Daily
Practicality
Udaya.com tracking system X X
Satisfaction survey X
PTSD symptoms
Impact of Event Scale-Revised X X X
Comorbid conditions
State-Trait Anxiety Inventory (anxiety) X X X




Self-Compassion Scale X X X
Emotional regulation
Emotional Regulation Questionnaire X X X
Grief
Perinatal Grief Scale X X X
Sleep quality
GENEActiv X X X
Pittsburgh Sleep Quality Index X X X
Physical activity






Borg Rating of Perceived Exertion
Scale
Daily
Meditative Movement Inventory Daily
Self-rated health
Short-Form 12 Health Survey X X
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≥70%, and (3) attendance (i.e., at least 70% of partici-
pants in the moderate dose group will complete 150 min
of yoga/week for at least nine of the 12 weeks (75%), at
least 70% of participants in the low dose group will
complete 60 min of yoga/week) for at least nine of the
12 weeks (75%). For the control group, our benchmarks
will be as follows: (1) feasibility (i.e., satisfaction, appro-
priate, acceptable ≥70%) and (2) attendance (i.e., at least
70% of the control group will complete 60 min of
stretching, toning, and limbering/week for at least nine
of the 12 weeks (75%).
PTSD symptoms The IES-R has three subscales (i.e.,
avoidance, intrusion, hyperarousal), and the sum of the three
subscale scores produce the total IES-R score. All subscale
scores have demonstrated high internal consistency and
have been validated in postpartum populations [63]. A total
IES-R score is clinically significant, and ≥33 signifies the
likely presence of PTSD [64].
Anxiety The State-Trait Anxiety Inventory (STAI) yields
scores indicating levels of trait (Form Y-1) and state anx-
iety (Form Y-2). The STAI has demonstrated reliability
and validity in pregnant and postpartum populations
[65, 66]. Higher scores indicate greater anxiety.
Depression The Patient Health Questionnaire-9 (PHQ-
9) [67] is a valid and reliable (α = 0.86–0.89) measure
used to screen, diagnose, monitor, and measure the se-
verity of depression and has been validated in pregnant
and postpartum populations [68–70]. Scores range from
0–27, and cut-off scores of 5, 10, 15, and 20 represent
mild, moderate, moderately severe, and severely depres-
sive symptoms, respectively.
Self-compassion The Self-Compassion Scale (SCS) is a
26-item questionnaire with good construct validity and
reliability (α = 0.92) [71]. Higher scores indicate higher
levels of self-compassion.
Emotional regulation The Emotional Regulation Ques-
tionnaire (ERQ) is a valid 10-item scale used to measure
an individual’s tendency to regulate their emotions by
two strategies (i.e., cognitive reappraisal and expressive
suppression) [72]. The higher the scores, the greater the
use of the emotional regulation strategy.
Mindfulness The Mindful Attention Awareness Scale
(MAAS) is a valid and reliable measure with good internal
consistency (α = 0.80–0.87) [73]. This scale includes 15
items and measures the extent to which individuals are
able to maintain awareness of present-moment experi-
ence. Higher scores reflect higher levels of mindfulness.
Grief The Perinatal Grief Scale (PGS) is a valid 33-item
instrument used to quantify the grief of perinatal loss
[74]. The PGS consists of three subscales (i.e., active
grief, difficulty coping, and despair). Higher scores indi-
cate more intense grief.
Self-rated health The Short-Form Health Survey (SF-12)
was developed for the Medical Outcomes Study (MOS)
and is modified from the original 36-item survey [75]. The
SF-12 is a valid scale that includes 12 items that measure
eight domains of health-related quality of life (i.e., physical
functioning, role physical, bodily pain, general health, vi-
tality, social functioning, role emotional, and mental
health). The items are scored using standard scoring algo-
rithms explained elsewhere [76]. Scores range from 0
(lowest level of health) to 100 (highest level of health).
Subjectively measured sleep quality The Pittsburgh
Sleep Quality Index (PSQI) is a 19-item questionnaire
[77]. The PSQI has demonstrated reliability and validity
in pregnant populations [78]. Higher global PSQI scores
indicate more sleep disturbances.
Subjectively measured physical activity: The past-week
Modifiable Activity Questionnaire (PWMAQ) is a valid
and reliable self-report measure (α = 0.82) [79]. Respon-
dents report the number of minutes spent in 38 different
activities, and each activity is summed. Using the Com-
pendium of Physical Activities, a MET value of >3.0 will
be applied to each reported activity (at least a moderate-
intensity). Participants will be categorized as meeting
physical activity guidelines if they reported at least
150 min of moderate-intensity physical activity during
the past week.
Objectively measured sleep quality and physical
activity The GENEActiv (ActivInsights, Kimbolton, UK)
accelerometer will be used to provide an objective, non-
invasive 24-h Assessment of Sleep-Wake and Physical
Activity patterns. Wrist actigraphy has been extensively
validated as a measure of sleep-wake activity as com-
pared to the gold standard sleep measure, polysomno-
graphy, in samples from infants to older adults [80–82].
The GENEActiv also has been validated for sedentary
behavior and postural allocation (i.e., sitting vs. stand-
ing), and moderate to vigorous physical activity [83, 84].
Bed times and wake times (to define the sleep interval)
will be derived from brief daily diaries which can be
completed in less than 1 min.
Sample size
We aim to enroll 90 participants. Assuming an attrition
rate of 20%, we will have a final sample of 72 women
with data through a 20-week follow-up. This sample size
is appropriate for early-phase developmental trials [60].
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While we do not intend to fully power our exploratory
aim 3, we do anticipate sufficient power to detect a large
effect (to detect a large effect of Cohen’s d = .80) be-
tween a treatment arm and control group on primary
(PTSD symptoms) and secondary (anxiety, depression,
self-compassion, emotional regulation, sleep disturb-
ance) outcomes with n = 72 (p < 0.05, power = 0.80). The
power of the study is such that large effects will be
detectable and the directionality of effects will be suffi-
ciently stable to assess the preliminary merit of the inter-
vention and provide information needed for future
larger studies. Effect sizes will be calculated along with
tests of significance. Effects of intervention on physical
activity, mindfulness, and perceived exertion will be ex-
plored using mixed models or multilevel models to
examine multiple waves of data from weekly logs and
GENEActiv. Effects of intervention should emerge as
significant regression coefficients for the group member-
ship predictor in accounting for within-person intercepts
and slopes. Planned contrasts will compare three groups
(LD, MD, and control) for differing trajectories over
time. If both yoga groups show greater improvements
on outcomes than the control group and there are sig-
nificant differences between LD and MD, this would in-
dicate that one group may lead to improved outcomes.
If both yoga groups improved more than the control
group, and there are no significant differences between
LD and MD, we will use feasibility data to determine
which group is more feasible.
Recruitment
We will nationally recruit and screen participants via a
web-based survey (i.e., Qualtrics). We will work with
non-profit partners who provide support for bereaved
parents (e.g., MISS Foundation, Star Legacy Foundation)
to actively recruit participants. We will also heavily
utilize web-based strategies including social media (i.e.,
Facebook, Twitter), social networking sites, online
stillbirth support groups (e.g., SOBBS, Compassionate
Friends), and email LISTSERV. We will make a con-
certed effort to recruit minority women utilizing the in-
formation learned from the interviews with minority
women in phase 1. Note: recruitment for the iterative
design process in phase 1 will involve contacting local
organizations following the same strategies above.
Study enrollment
Interested participants will complete an eligibility
screener (approximately 5–10 min) on Qualtrics. The
screener will only allow one entry per IP address to pre-
vent “ballot box stuffing.” Additionally, there will be a
final question on the screener asking the participant to
confirm all responses. Upon submitting the screener,
participants will no longer have access to the screener.
Research team members will follow an Institutional
Review Board (IRB)-approved script to respond to inter-
ested participants who phone or email and refer them to
the eligibility screener (participants provide consent
electronically to complete the eligibility screener). All in-
eligible participants will be notified by phone and/or
email and offered a discounted Udaya.com membership
($9/mo., compared to $12/mo.)
Phase 1
Iterative design: Eligible participants (see Table 1 for eli-
gibility criteria) will receive an email requesting times to
schedule their first visit to the lab on the university cam-
pus. During the participant’s first visit, they will complete
an informed consent document.
Interviews: Eligible participants will receive an email
requesting times to schedule their 15–20-min phone
interview. Following, participants will be sent a Qualtrics
link asking them to electronically sign an informed con-
sent document before their scheduled interview.
Phase 2
Eligible participants (see Table 2 for eligibility criteria)
will be asked to complete a phone intake appointment,
an electronic informed consent, a HIPAA authorization
form, and baseline assessments of self-report measures
(see Table 3). Participants will then be randomized to an
intervention (LD or MD) or control group. The research
team will mail intervention group participants: (1) a
packet with study info and directions, (2) a document
including strategies to overcome barriers to online yoga
participation, (3) an accelerometer (GENEActiv) with in-
structions on how to wear, and (4) a yoga mat, two
blocks, and a strap. The control group will receive (1) a
packet with study info and directions, (2) a document
including strategies to overcome barriers to online
physical activity participation, (2) an accelerometer
(GENEActiv) with instructions on how to wear and a
pre-paid return mailer, and (3) a stretching mat and
band. All participants will be asked to begin wearing
the GENEActiv immediately upon receiving it for one
full week and then mail monitor back in a pre-paid en-
velope supplied in their packet. The GENEActiv will
be mailed to participants again at post-intervention
(12 weeks from baseline) and follow-up (20 weeks
from baseline) using the same process. When participants
have worn the GENEActiv for 1 week, they will be emailed
their UDAYA username and password to begin accessing
their respective videos.
Confirming participants’ identity/eligibility
During the intake phone call, we will confirm the partic-
ipant’s identity and eligibility with the following:
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1. Confirmation of answers from the eligibility screener
(i.e., date of the stillbirth delivery, cause if known,
location of death).
2. A small sample of women (~30%; N = 27) will be
asked to verify information about their baby’s death
to confirm their eligibility based on stillbirth history.
All women will be asked to sign a HIPAA
authorization form at the same time in which they
sign their informed consent (in the case where they
are randomly selected for research staff to obtain
medical records related to the death of their baby).
As women enter the study and are assigned an ID,
those with an ID that matches one contained in a
random number table generated prior to
recruitment into the study will be selected.
3. The research team will request the records (e.g., date,
gestational age, birthweight, and Apgar scores). If
there is a significant number of women who are
ineligible (>30%), we will increase the number that
we confirm eligibility to ~40% using medical
records.
Allocation (phase 2 only)
Block randomization will be used to assign participants
to treatment groups. Specifically, the biostatistician will
construct 15 blocks of six participants using SAS PROC
PLAN with a random number seed known only by the
biostatistician. This will be done at the beginning of the
study (front-loaded) and provided to a research staff
member not associated with this study (i.e., trusted bro-
ker). The trusted broker will utilize the treatment alloca-
tions to sequentially assign enrollees to randomized
treatment groups (the biostatistician will be shielded
from enrollment date and enrollment order, and partici-
pant IDs will not reflect enrollment order). The trusted
broker will hold the codes that match participants to
treatment groups. Research staff members will call the
trusted broker to determine assignment to group. In
case of adverse events (AE), the research staff member
will call the trusted broker to provide for unblinding
(AE only). After randomization, participants will be
emailed a study information packet (i.e., instructions,
UDAYA username/password) according to the interven-
tion assigned. The initiation of the study will begin after
allocation to study arm (see Fig. 2 for phase 2 study flow
chart).
Blinding (phase 2 only)
The principal investigator and biostatistician will remain
blinded until the completion of data collection (i.e., data
is locked). Following the conclusion of data collection
(i.e., data is locked), the biostatistician will be unblinded
as data analysis will require knowledge of treatment as-
signment. The study coordinator and graduate student
worker that deliver the intervention(s) and prepare re-
ports to the Independent Monitoring Committee (IMC)
will be unblinded. The study coordinator will be respon-
sible for the intervention groups, and the graduate
student worker will be responsible for the control group.
A research staff not directly involved in the study will
serve as the “trusted broker” to handle the sequential
assignment of participants to randomized treatment
groups and will also be unblinded.
Incentives
Phase 1 and 2 incentives are listed in Table 4.
Data management
The research participant will self-report data electronic-
ally via Qualtrics. Weekly, the research team will be re-
sponsible for ensuring the completeness and timeliness
of the data reported by the participants. Additionally,
the research team will skim the data after each collection
time point to ensure it is complete and will follow-up
with any participants in which data collection is not
complete.
Data quality will be monitored throughout the study.
Measurement values will be compared to their known
ranges. Out of range values will be investigated and
either corrected if possible or treated as missing data.
Statistical analyses will adjust for baseline demographic
characteristics when statistically appropriate. Multiple
imputations will be used to conduct statistical analysis
with missing data. In the event that the missing at ran-
dom assumption is violated, we will model the missing
data mechanism and conduct sensitivity analysis on
model parameters.
We have multiple strategies in place to identify yoga
participation both during video sessions and outside of
video sessions. First, we will be collecting 24-h, time-
stamped GENEActiv accelerometer data at baseline,
post-intervention (12 weeks), and follow-up (20 weeks)
and will have a full record of their activity level during
these time points. We will also be monitoring UDAYA
website log-in information and will be able to localize
activity monitor data while the participant is logged into
the website and using the yoga videos. This will allow us
to verify whether the participant is being active during
the times they are using the website. Second, we will col-
lect self-reported minutes of yoga using a log. This self-
report log will also give us a time stamp of yoga activity
that we will be able to cross-refer to the accelerometer
data. Finally, we will be able to monitor all other phys-
ical activities that are performed outside of yoga, exam-
ining whether the intervention may have unintended
effects of activity within other types of physical activity.
Collectively, we will have a full record of yoga and phys-
ical activity (outside of yoga) participation that we will
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be able to use to understand the “dosage” that is being
achieved for this trial.
Statistical analysis
Inferential analyses: To examine quantitative feasibility
measures, we will use Fisher’s exact tests when expected
cell counts <5 and t tests to compare feasibility scores
between the low and moderate dose groups. Significant
differences between the two groups will indicate which
yoga group is more feasible. We will also use logistic
and Gaussian regression analyses to further compare
feasibility scores between groups while adjusting for
baseline participant characteristics.
We will use Fisher’s exact tests and ANOVAs to com-
pare quantitative acceptability scores across control and
yoga groups. Logistic and Gaussian regression analyses
will be used to compare scores while adjusting for base-
line participant characteristics. We expect participants in
the control group to report similar levels of acceptability
compared to those in the yoga groups, but participants
in the yoga groups are expected to report greater im-
provements on outcomes than control participants.
Fig. 2 Phase 2 flow chart: This diagram illustrates a study flow chart adapted from the CONSORT and includes a blank template of what will
be reported
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Descriptive analyses: SPSS and R will be used to con-
duct descriptive statistical analyses, including graphical
analysis (e.g., scatter plots, boxplots and histograms) and
data summarization (e.g., means, medians, ranges, cross-
tabulations) to identify data entry errors, outliers, and
non-normal distributions. Standard errors and confi-
dence intervals will be calculated using either parametric
or non-parametric methodology, including the use of the
bootstrap to estimate standard errors when parametric
assumptions fail.
Data from the qualitative interviews will be transcribed
and independently coded by the research team using
NVivo. After coding is complete, researchers will meet
to reach agreement on major themes of the interviews.
Once the major themes have been determined, findings
will be verified through member checking to determine
accuracy of findings. Principal Investigator (PI) Huberty
and Co-I Cacciatore have extensive training and experi-
ence in qualitative methods.
Psychometric analyses: We will evaluate scale reliabil-
ities using Cronbach’s alpha coefficients based on base-
line (T1) data. Scale inter-correlations will be estimated
along with complete descriptive statistics on scale items.
Randomization check: We will also conduct an ANOVA
to compare the experimental and control groups on out-
come and demographic variables at baseline.
Missing data
Substantial missing data are anticipated in this study. Par-
ticipants may refuse to participate or withdraw from the
study at any time. In addition, daily and weekly logs may
not be complete despite efforts by research staff to en-
courage completion. Missing data due to non-response on
certain items within a scale will initially be handled by
creating an average scale score for all participants who
responded to at least 75% of items on that scale. We
will evaluate whether missingness due to attrition is
related to group membership and examine relations
between missingness and any missing individual’s pretest
scores on outcome variables. If missingness is found to
satisfy the missing at random assumption, we will handle
the missing data using multiple imputation. Multiple im-
putation will also be used to handle item-level missingness
for final analyses of scales. In the event that the missing at
random assumption is violated, we will model the missing
data mechanism and conduct sensitivity analysis on model
parameters. All analyses will retain all participants who
were assigned to the intervention or control groups (i.e.,
intent to treat).
Data monitoring
Due to the nature of this study, an IMC will be established
and comprised of four committee members. Due to their
combined expertise related to stillbirth care, biostatistics,
NIH-funded studies, and yoga safety, they are qualified to
review the patient safety data generated by this study.
Adverse events
An AE is any untoward medical occurrence in a subject
during participation in the clinical study or with use of
the experimental agent being studied. An adverse finding
can include a sign, symptom, abnormal assessment
(laboratory test value, vital signs, electrocardiogram
finding, etc.) or any combination of these regardless of
relationship to participation in the study. Adverse events
that are non-serious will be provided to the IMC with
summaries of the numbers and rates of AEs by group.
Expedited review will occur for all events meeting the
FDA definition of serious adverse events (SAEs), i.e., any
fatal event, immediately life-threatening event, and per-
manently or substantially disabling event. This also in-
cludes any event that a study investigator or the IMC
judges to impose a significant hazard, contraindication,
side effect, or precaution. For purposes of this study, all
SAEs will be reported to the IMC regardless of any judg-
ment of their relatedness to the study treatment.
Table 4 Incentive schedule
Phase Time point Incentive
Phase 1—iterative design Completion of review of 9 yoga videos •Free 1 month membership to UDAYA
•$15/session (up to $135 gift card)b
Phase 1—interviews Completion of 15-min interview $15 gift cardb
Phase 2 Enrollment •Intervention groups: yoga mat, 2 blocks, and strap
•Control group: stretching mat and band






aAll groups receive incentive
bParticipant has choice of gift card from Amazon, Bath & Body Works, Starbucks, or Target
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The PI will record all reportable events with start dates
occurring any time after informed consent is obtained
until 7 (for non-serious AEs) or 30 days (for SAEs) after
the last day of study participation. Each week, partici-
pants will report in their weekly logs the occurrence of
AE/SAEs since the last week. If the participants are not
completing their logs, they will be prompted via email
by the research team to complete their logs. If there are
two consecutive failed email attempts, the participants
will be called. Events will be followed for outcome infor-
mation until resolution or stabilization.
The research team will determine if the event is an AE
or an SAE. If an SAE, the research team will complete a
form to be provided to the IMC to meet and investigate
the SAE until determined resolved or stable and its rela-
tion to the study (related or not related). Once recruit-
ment begins, IMC will meet twice a year and will meet
ad hoc when AE or an SAE occur. AE reports and an-
nual summaries will not include individual identifiable
private information about the human subjects. Each re-
port will only include the identification code previously
assigned.
At 6 weeks (midway through the intervention), partici-
pants will be asked to complete the IES-R and answer a
1-item Likert-based question related to whether they
think the intervention is contributing to their symptoms
for the IMC to review. Every 2 weeks of the intervention,
participants will be asked to fill out the PHQ-9 via Qual-
trics within 48 h. A research team member will monitor
PHQ-9 completion daily (including weekend/holidays).
Women with scores suggestive of clinical depression
(>15) will be notified and advised to follow up with their
primary care physician. If suicidal ideation is noted with
a screen score of two or three on question 9 of the
PHQ-9, the participant will be contacted within 24 h by
a crisis-trained, clinical staff for further assessment of
risk. Clinical providers trained by the MISS Foundation
are well equipped to handle psychological crises, have a
system currently used for their existing 3000 grieving
families they help annually, and have staff available on
weekends/holidays. If imminent suicidal risk is present,
the staff will follow MISS Foundation emergency proce-
dures to ensure participant safety, and the participant
will be discontinued from the study. If there are no con-
cerns for active suicidal risk after the phone assessment,
the participant will be able to continue in the study if
she desires. All participants will have the MISS Founda-
tion provider’s phone number, and the research
personnel can either email, call, text, or page the lead
clinical provider to respond to psychiatric issues. De-
pending on the need of the participant, one of them will
be able to talk to a clinician within 2 to 3 h.
If at any time during the study a participant should call
a member of the research team emotionally distressed, not
making clear sense, sounding intoxicated or impaired, or
expressing thoughts of suicide or homicide, the research
personnel will use a second phone line to contact the
counselor, without losing verbal contact with the woman.
At that point, the clinician will guide the interview to as-
certain the acuity and/or potential for harm and will first
determine if the caller is alone or has access to another
adult capable of transportation. If determined that the
woman is in need of emergent care, options for such care
will be discussed with the caller and may include referral
to the closest emergency room (ER), notification of emer-
gency services for transportation to the nearest ER, and
emergent counseling appointment coordinated by the
MISS Foundation or their preferred provider. If the sub-
ject declines such a referral and the clinician remains con-
cerned about the participant’s safety, emergency services
in her area (determined during the consent process) will
be notified of the clinical concern for safety.
Reporting
The PI will report any incidents, i.e., adverse events
(AEs) or serious adverse events (SAEs), that meet the
Office for Human Research Protections (OHRP) criteria
for unanticipated problems. The PI will complete a form
with the following information to the IRB: (1) appropri-
ate identifying information for the research protocol (i.e.,
title, investigator’s name, IRB project number); (2) a de-
tailed description of the adverse event, incident, experi-
ence, or outcome; (3) an explanation of the basis for
determining that the adverse event, incident, experience,
or outcome represents an unanticipated problem; and
(4) a description of any changes to the protocol or other
corrective actions that have been taken or are proposed
in response to the unanticipated problem. Unanticipated
problems that are serious adverse events will be reported
to the IRB, IMC, and National Center for Complemen-
tary and Integrative Health (NCCIH) within 7 days, and
any other unanticipated problem will be reported within
14 days of the investigator becoming aware of the
problem/event. All unanticipated problems should be
reported to the appropriate institutional officials (as re-
quired by an institution’s written reporting procedures),
the supporting agency head (or designee), and the OHRP
within 1 month of IRB’s receipt of the report of the
problem from the investigator.
Study progress and safety will be reviewed monthly
(and more frequently if needed). Progress reports, in-
cluding patient recruitment, retention/attrition, AEs, and
SAEs, will be provided to the IMC semi-annually. An
annual report will be compiled and will include a list
and summary of AEs and SAEs and will address (1)
whether AE/SAE rates are consistent with pre-study as-
sumptions, (2) the reason for dropouts from the study, (3)
whether all participants met entry criteria, (4) whether
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continuation of the study is justified on the basis that add-
itional data are needed to accomplish the stated aims of
the study, and (5) the conditions whereby the study might
be terminated prematurely. The annual report will be sent
to the IMC and will be forwarded to the IRB and NCCIH.
The IRB and other applicable recipients will review
progress of this study on an annual basis. The study
team will generate study reports for the IMC and will pro-
vide information on the following study parameters: en-
rollment status, subject status, demographics, stopping or
halting rules, unanticipated problems, adverse events,
protocol deviations, quality management, and outcome
data (if applicable at time of report). Study report tables
will be generated only from aggregate (not by group as-
signment) baseline and aggregate safety data for the study
population.
Research ethics approval
The Arizona State University Institutional Review Board
has approved all protocols, data and safety monitoring
plans, and study materials. All protocol amendments,
other than minor administrative changes as defined by
the NCCIH Guidance on Changes in Clinical Studies in
Active Awards, will be submitted in a prospective man-
ner to NCCIH except when necessary to protect the
safety, rights, or welfare of subjects. Prior to submission
to NCCIH, the proposed changes will be reviewed and
approved by the IMC. IRB approval will not be sought
until after NCCIH approval of the protocol amendment
has been obtained.
Informed consent
All consent documents will be obtained electronically,
via Qualtrics, prior to the woman’s participation in the
study (phase 1 or phase 2). The consent form will de-
scribe the purpose of the study, the procedures to be
followed, and the risks and benefits of participation. A
PDF copy will be emailed to the participants at their
request.
Timeline
See Table 5 for project timeline.
Discussion
This RCT study will explore the feasibility and accept-
ability of a 12-week, home-based, online-streamed yoga
intervention, with varying doses (low = 60 min/week;
moderate = 150 min/week) among bereaved mothers
who have experienced a stillbirth within 6 weeks to
24 months. To date, this is the first study to ascertain
the preliminary effects of home-based, online-streamed
yoga on reducing PTSD symptoms below the clinical
threshold in mothers who have experienced the death of
a baby to stillbirth. This study is particularly important
Table 5 Project timeline
Item Year 1—months Year 2—months Year 3—months
1–2 3–4 5–6 7–8 9–10 11–12 13–14 15–16 17–18 19–20 21–22 23–24 25–26 27–28 29–30 31–32 33–34 35–36
Hire research personnel X X
Continue to engage non-for profit
partnerships
X X X X X
Finalize manual of procedures for
all protocols
X X
Finalize participant materials X
Finalize control group prescription X
Finalize Udaya yoga prescription X
Develop recruitment plans and
materials
X X
Train research staff on study
rocedures
X
Modifications to Udaya.com (i.e.,
fidelity tracking, filming control
group sessions)
X X X
Obtain IRB approval X
Recruitment and enrollment X X X X
Baseline data collection X X X X X
Post data collection X X X X X
Follow-up data collection X X X X X
Data analysis X X X X X X X
Manuscript preparation X X X X X X X X
Grant preparation X X X X X X X X X
Huberty et al. Pilot and Feasibility Studies  (2018) 4:12 Page 13 of 16
not only because the risk for PTSD is nearly seven times
the risk as compared to that for mothers with live births
but also because there have only been two randomized
control trials in the last 30 years aimed at improving
emotional and mental health in these grieving mothers,
which also affects surviving and subsequently born
children. If feasible, the findings from this study will in-
form a full-scale trial to determine the effectiveness of
home-based, online-streamed yoga to improve PTSD.
Long-term, health care providers could use online yoga
as a non-pharmaceutical, inexpensive resource to help
women manage their symptoms after a stillbirth.
Abbreviations
AE: Adverse event; ER: Emergency room; ERQ: Emotional Regulation Questionnaire;
HIPAA: Health Insurance Portability and Accountability Act; IES-R: Impact of Event
Scale-Revised; IMC: Independent Monitoring Committee; IRB: Institutional Review
Board; LD: Low dose; MAAS: Mindful Attention Awareness Scale; MD: Moderate
dose; NCCIH: National Center for Complementary and Integrative Health;
NIH: National Institutes of Health; PGS: Perinatal Grief Scale; PHQ-9: Patient Health
Questionnaire-9; PSQI: Pittsburgh Sleep Quality Index; PWMAQ: Past-week
Modifiable Activity Questionnaire; RCT: Randomized controlled trial; SAE: Serious
adverse event; SCS: Self-Compassion Scale; STAI: State-Trait Anxiety Inventory;
STC: Stretch and tone control
Acknowledgements
The authors would like to acknowledge Jules Mitchell for her expertise and
contributions to the workpresented here.
Funding
This study is supported by the National Institutes of Health and National
Center for Complementary and Integrative Health (1R34AT008808-01A1). The
study was designed and conceived independently of the study funder and
sponsor, and neither will have any role in the collection, management,
analysis, and interpretation of the data or in the writing of the full report.
Availability of data and materials
Not applicable.
Authors’ contributions
JH, JL, JC, and KG made the study concept and design. JH and JM are
responsible for the manuscript preparation. JH, JM, JL, JC, and KG
participated in the manuscript editing/revising. JM carried out the data




The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The Institutional Review Board at Arizona State University approved this
study, and all participants will consent to participate. Reference number:
STUDY00004266.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1School of Nutrition and Health Promotion, Arizona State University, 500 N.
3rd St, Phoenix, AZ 85004, USA. 2Colorado School of Public Health, University
of Colorado Denver, 13001 E. 17th Place, B119, Bldg 500, Room E3341,
Anschutz Medical Campus, Aurora, CO 80045, USA. 3School of Social Work,
Arizona State University, 411 N. Central, 8th Floor, Phoenix, AZ 85004, USA.
4Department of Family Medicine, Department of Obstetrics & Gynecology,
University of Michigan, 1018 Fuller Street, Ann Arbor, MI 48104-1213, USA.
Received: 9 March 2017 Accepted: 15 June 2017
References
1. Macdorman MF, Kirmeyer S. The challenge of fetal mortality. NCHS Data
Brief. 2009;16(16):1–8.
2. Heazell A, Siassakos D, Blencowe H, Burden C, Bhutta Z, Cacciatore J, Dang
N, Das J, Flenady V, Gold K, Mensah O, Millum J, Nuzum D, O'Donoghue K,
Redshaw M, Rizvi A, Roberts T, Saraki H, Storey C, Wojcieszek A, Downe S.
Lancet Ending Preventable Stillbirths, Lancet Ending Preventable Stillbirths
investigator group, Lancet Ending Preventable Stillbirths Series study group:
Stillbirths: economic and psychosocial consequences. Lancet. 2016;
387(10018):604–16.
3. Scheidt CE, Hasenburg A, Kunze M, Waller E, Pfeifer R, Zimmermann P,
Hartmann A, Waller N. Are individual differences of attachment predicting
bereavement outcome after perinatal loss? A prospective cohort study.
J Psychosom Res. 2012;73(5):375–82.
4. Cacciatore J. Psychological effects of stillbirth. Semin Fetal Neonatal Med.
2013;18(2):76–82.
5. Wayment HA, Vierthaler J. Attachment style and bereavement reactions.
J Loss and Trauma. 2002;7(2):129–49.
6. Cacciatore J, Rådestad I, Frederik Frøen J. Effects of contact with stillborn
babies on maternal anxiety and depression. Birth. 2008;35(4):313–20.
7. Cacciatore J. The unique experiences of women and their families after the
death of a baby. Soc Work Health Care. 2010;49(2):134–48.
8. Gravensteen IK, Helgadottir LB, Jacobsen EM, Radestad I, Sandset PM,
Ekeberg O. Women’s experiences in relation to stillbirth and risk factors for
long-term post-traumatic stress symptoms: a retrospective study. BMJ Open.
2013;3(10):e003323.
9. Armstrong DS, Hutti MH, Myers J. The influence of prior perinatal loss on
parents’ psychological distress after the birth of a subsequent healthy infant.
J Obstet Gynecol Neonatal Nurs. 2009;38(6):654–66.
10. Turton P, Hughes P, Evans CD, Fainman D. Incidence, correlates and
predictors of post-traumatic stress disorder in the pregnancy after stillbirth.
Br J Psychiatry. 2001;178:556–60.
11. Wojcieszek A: Ending preventable stillbirths. The Lancet. 2016;387(10019):
691-702.
12. Lawn J, Kinney M. Stillbirths: an executive summary for The Lancet’s Series.
Lancet. 2011;1-8.
13. Gold K, Leon I, Boggs M, Sen A. Depression and posttraumatic stress
symptoms after perinatal loss in a population-based sample. J Womens
Health. 2016;25(3):263–9.
14. Gold K, Boggs M, Muzik M, Sen A. Anxiety disorders and obsessive
compulsive disorder 9 months after perinatal loss. Gen Hosp Psychiatry.
2014;36(6):650–4.
15. Christiansen DM, Elklit A, Olff M. Parents bereaved by infant death: PTSD
symptoms up to 18 years after the loss. Gen Hosp Psychiatry. 2013;35(6):605–11.
16. Grekin R, O'Hara MW. Prevalence and risk factors of postpartum posttraumatic
stress disorder: a meta-analysis. Clin Psychol Rev. 2014;34(5):389–401.
17. Turton P, Evans C, Hughes P. Long-term psychosocial sequelae of stillbirth:
phase II of a nested case-control cohort study. Arch Womens Ment Health.
2009;12(1):35–41.
18. Cote-Arsenault D, Marshall R. One foot in–one foot out: weathering the
storm of pregnancy after perinatal loss. Res Nurs Health. 2000;23(6):473–85.
19. Flenady V, Wilson T. Support for mothers, fathers and families after perinatal
death. Cochrane Database Syst Rev. 2008;(1:CD000452. doi(1):CD000452.
20. Huberty JL, Matthews J, Leiferman J, Hermer J, Cacciatore J. When a Baby
Dies: A Systematic Review of Experimental Interventions for Women After
Stillbirth. Reproductive Sciences. 2016;1933719116670518.
21. Lake MF, Johnson TM, Murphy J, Knuppel RA. Evaluation of a perinatal grief
support team. Obstet Gynecol. 1987;157(5):1203–6.
22. Roberts LR, Montgomery SB. Mindfulness-based intervention for perinatal
grief after stillbirth in rural India. Issues Ment Health Nurs. 2015;36(3):222–30.
23. Jeffries FW, Davis P. What is the role of eye movements in eye movement
desensitization and reprocessing (EMDR) for post-traumatic stress disorder
(PTSD)? A review. Behav Cogn Psychother. 2013;41(03):290–300.
Huberty et al. Pilot and Feasibility Studies  (2018) 4:12 Page 14 of 16
24. Lapp LK, Agbokou C, Peretti C, Ferreri F. Management of post traumatic
stress disorder after childbirth: a review. J Psychosomatic Obstetrics
Gynecology. 2010;31(3):113–22.
25. Cacciatore J, Bushfield S. Stillbirth: the mother’s experience and implications
for improving care. J Social Work in End-Life Palliative Care. 2007;3(3):59–79.
26. Chambers HM, Chan FY. Support for women/families after perinatal death.
The Cochrane database of systematic reviews. 2000;2:CD000452.
27. Lacasse JJR. Prescribing of psychiatric medication to bereaved parents
following perinatal/neonatal death. Death Stud. 2014;38(9):589. 589-596.
28. Cacciatore JJ. Pharmacological treatment following traumatic bereavement:
a case series. Journal of loss & trauma. 2012;17(6):557. 557-579; 579.
29. Cacciatore J. Effects of support groups on post traumatic stress responses in
women experiencing stillbirth. Omega (Westport). 2007;55(1):71–90.
30. DiMarco MA, Menke EM, McNamara T. Evaluating a support group for
perinatal loss. MCN Am J Matern Child Nurs. 2001;26(3):135–40.
31. Bennett SSM. An exploratory study of the psychological impact and clinical
care of perinatal loss. J loss & trauma. 2008;13(6):485. 485-510; 510.
32. Huberty J, Coleman J, Rolfsmeyer K, Wu S. A qualitative study exploring
women’s beliefs about physical activity after stillbirth. Bmc Pregnancy And
Childbirth. 2014;14(1):26.
33. Conry J, Prinsloo C. Mothers’ access to supportive hospital services after the
loss of a baby through stillbirth or neonatal death: research. Health SA
gesondheid. 2008;13(2):14–24.
34. Gold KJ, Boggs ME, Mugisha E, Palladino CL. Internet message boards for
pregnancy loss: who’s on-line and why? Womens Health Issues. 2012;22(1):e67–72.
35. Uebelacker LA, Tremont G, Epstein-Lubow G, Gaudiano BA, Gillette T,
Kalibatseva Z, Miller IW. Open trial of Vinyasa yoga for persistently
depressed individuals: evidence of feasibility and acceptability. Behavior
Modification. 2010;34(3):247-64.
36. Bershadsky S, Trumpfheller L, Kimble HB, Pipaloff D, Yim IS. The effect of
prenatal Hatha yoga on affect, cortisol and depressive symptoms.
Complement Ther Clin Pract. 2014;20(2):106–13.
37. Kinser PA, Elswick RK, Kornstein S. Potential long-term effects of a mind-
body intervention for women with major depressive disorder: Sustained
mental health improvements with a pilot yoga intervention. 2014;28:377-83.
38. Narendran S, Nagarathna R, Narendran V, Gunasheela S, Nagendra HRR.
Efficacy of yoga on pregnancy outcome. J Alternative & Complementary
Medicine. 2005;11(2):237–44.
39. Reis PJ, Alligood MR. Prenatal yoga in late pregnancy and optimism, power,
and well-being. Nurs Sci Q. 2014;27(1):30–6.
40. Ross A, Friedmann E, Bevans M, Thomas S. Frequency of yoga practice
predicts health: results of a national survey of yoga practitioners. Evid Based
Complement Alternat Med. 2012;2012:983258.
41. Telles S, Singh N, Balkrishna A. Managing mental health disorders resulting
from trauma through yoga: a review. Depress Res Treat. 2012;2012:401513.
42. Emerson D, Sharma R, Chaudhry S, Turner J. Trauma-sensitive yoga:
principles, practice, and research. International Journal of Yoga Therapy.
2009;19(1):123–8.
43. Mitchell KS, Dick AM, DiMartino DM, Smith BN, Niles B, Koenen KC, Street A.
A pilot study of a randomized controlled trial of yoga as an intervention for
PTSD symptoms in women. J Trauma Stress. 2014;27(2):121–8.
44. Seppälä EM, Nitschke JB, Tudorascu DL, Hayes A, Goldstein MR, Nguyen DT,
Perlman D, Davidson RJ. Breathing-based meditation decreases posttraumatic
stress disorder symptoms in US military veterans: a randomized controlled
longitudinal study. J Trauma Stress. 2014;27(4):397–405.
45. Staples JK, Hamilton MF, Uddo M. A yoga program for the symptoms of
post-traumatic stress disorder in veterans. Mil Med. 2013;178(8):854–60.
46. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K,
Hróbjartsson A, Mann H, Dickersin K, Berlin J, Doré C, Parulekar W,
Summerskill W, Groves T, Schulz K, Sox H, Rockhold FW, Rennie D, Moher D.
SPIRIT 2013 statement: defining standard protocol items for clinical trials.
Ann Intern Med. 2013;158:200–7.
47. Gothe NP, Mullen SP, Wojcicki TR, Mailey EL, White SM, Olson EA, Szabo AN,
Kramer AF, McAuley E. Trajectories of change in self-esteem in older adults:
exercise intervention effects. J Behav Med. 2011;34(4):298–306.
48. McAuley E, Jerome GJ, Marquez DX, Elavsky S, Blissmer B. Exercise self-
efficacy in older adults: social, affective, and behavioral influences. Annals of
Behav Medicine. 2003;25(1):1–7.
49. McAuley E, Katula J, Mihalko SL, Blissmer B, Duncan TE, Pena M, Dunn E.
Mode of physical activity and self-efficacy in older adults: a latent growth
curve analysis. J Gerontol Ser B Psychol Sci Soc Sci. 1999;54(5):283–P292.
50. Wójcicki TR, Szabo AN, White SM, Mailey EL, Kramer AF, McAuley E. The
perceived importance of physical activity: associations with psychosocial
and health-related outcomes. J Phys Act Health. 2013;10(3):343.
51. Huberty, JL. Matthews, J. Leiferman, J. Cacciatore, J.: Experiences of women
who participated in a beta-test for an online-streamed yoga intervention
after a stillbirth. International Journal of Yoga Therapy (In review),.
52. Bussing A, Michalsen A, Khalsa SB, Telles S, Sherman KJ. Effects of yoga on
mental and physical health: a short summary of reviews. Evid Based
Complement Alternat Med. 2012;2012:165410.
53. Cowen VS, Adams TB. Heart rate in yoga asana practice: a comparison of
styles. J Bodywork Move Ther. 2007;11(1):91.
54. Field T. Yoga clinical research review. Complement Ther Clin Pract. 2011;17(1):1–8.
55. Ross A, Thomas S. The health benefits of yoga and exercise: a review of comparison
studies. The j alternative and complementary medicine. 2010;16(1):3–12.
56. American College of Sports Medicine (ACSM): Guidelines for exercise testing
and prescription. In 9th edition. Edited by Anonymous. Philadelphia:
Lippincott Williams & Wilkins; 2013:46.
57. Brisbon NM, Lowery GA. Mindfulness and levels of stress: a comparison
of beginner and advanced Hatha yoga practitioners. J Relig Health.
2011;50(4):931–41.
58. Mullen SP, Olson EA, Phillips SM, Szabo AN, Wójcicki TR, Mailey EL, Gothe
NP, Fanning JT, Kramer AF, McAuley E. Measuring enjoyment of physical
activity in older adults: invariance of the physical activity enjoyment scale
(paces) across groups and time. Int J Behav Nutr Phys Act. 2011;8(1):103.
59. McAuley E, Courneya KS, Rudolph DL, Lox CL. Enhancing exercise
adherence in middle-aged males and females. Preventive Medicine. 1994;23:
498–506.
60. Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken
S, Kaplan CP, Squiers L, Fabrizio C. How we design feasibility studies.
Am J Prev Med. 2009;36(5):452–7.
61. Berg BL, Lune H, Lune H. Qualitative research methods for the social
sciences. MA: Pearson Boston; 2004.
62. Marshall, Catherine, and Gretchen B. Rossman. Designing qualitative
research. Far East Square. Singapore: Sage publications; 2014.
63. Olde E, Kleber RJ, van der Hart O, Pop VJ. Childbirth and posttraumatic
stress responses: a validation study of the Dutch impact of event scale–revised.
Eur J Psychol Assess. 2006;22(4):259–67.
64. Weiss DS MC. The impact of event scale–revised. In: Wilson JP, Keane TM,
editors. Assessing psychological trauma and PTSD. New York: Guilford;
1997. p. 399–411.
65. Dennis C, Coghlan M, Vigod S. Can we identify mothers at-risk for
postpartum anxiety in the immediate postpartum period using the
State-Trait Anxiety Inventory? J Affect Disord. 2013;150(3):1217–20.
66. Spielberger CD. State-trait anxiety inventory: a comprehensive bibliography.
Palo Alto: Consulting Psychologists Press; 1993.
67. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression
severity measure. J Gen Intern Med. 2001;16(9):606–13.
68. Ji S, Long Q, Jeffrey Newport D, Na H, Knight B, Zach EB, Morris NJ, Kutner
M, Stowe ZN. Validity of depression rating scales during pregnancy and
the postpartum period: impact of trimester and parity. J Psychiatr Res.
2011;45(2):213–9.
69. Myers ER, Aubuchon-Endsley N, Bastian LA, Gierisch JM, Kemper AR, Swamy
GK, Wald MF, McBroom AJ, Lallinger KR, Gray RN, Green C, Sanders GD.
Efficacy and safety of screening for postpartum depression. US: Agency for
Healthcare Research and Quality; 2013.
70. O’Connor E, Rossom RC, Henninger M, Groom HC, Burda BU. Primary care
screening for and treatment of depression in pregnant and postpartum
women: evidence report and systematic review for the US Preventive
Services Task Force. JAMA. 2016;315(4):388–406.
71. Neff K. The development and validation of a scale to measure self-
compassion. Self Identity. 2003;2(3):223–50.
72. Gross JJ, John OP. Individual differences in two emotion regulation
processes: implications for affect, relationships, and well-being. J Pers Soc
Psychol. 2003;85(2):348.
73. Brown KW, Ryan RM. The benefits of being present: mindfulness and its role
in psychological well-being. J Pers Soc Psychol. 2003;84(4):822–48.
74. Toedter LJ, Lasker JN, Alhadeff JM. The Perinatal Grief Scale: development
and initial validation. Am J Orthopsychiatry. 1988;58(3):435.
75. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity. Med
Care. 1996;34(3):220–33.
Huberty et al. Pilot and Feasibility Studies  (2018) 4:12 Page 15 of 16
76. Ware JE. SF-36 physical & mental health summary scales: a manual for users
of version 1. United States: Quality Metric; 2001.
77. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh
Sleep Quality Index: a new instrument for psychiatric practice and research.
Psychiatry Res. 1989;28(2):193–213.
78. Skouteris H, Wertheim EH, Germano C, Paxton SJ, Milgrom J. Assessing sleep
during pregnancy. A study across two time points examining the Pittsburgh
Sleep Quality Index and associations with depressive symptoms. Womens
Health Issues. 2009;19(1):45–51.
79. Pettee Gabriel K, McClain JJ, Schmid KK, Storti KL, Ainsworth BE. Reliability
and convergent validity of the past-week Modifiable Activity Questionnaire.
Public Health Nutr. 2011;14(3):435–42.
80. Sadeh A. The role and validity of actigraphy in sleep medicine: an update.
Sleep Med Rev. 2011;15(4):259–67.
81. te Lindert B, Van Someren EJW. Sleep estimates using
microelectromechanical systems (MEMS). Sleep. 2013;36(5):781–9.
82. Lambert M. Updated guidelines from AASM for the treatment of central
sleep apnea syndromes. Am Fam Physician. 2012;86(10):968.
83. Rowlands AV, Olds TS, Hillsdon M, Pulsford R, Hurst T, Eston RG, Gomersall SR,
Johnston K, Langford J. Assessing sedentary behavior with the GENEActiv:
introducing the sedentary sphere. Med Sci Sports Exerc. 2014;46(6):1235–47.
84. Esliger DW, Rowlands AV, Hurst TL, Catt M, Murray P, Eston RG. Validation of
the GENEA accelerometer. Med Sci Sports Exerc. 2011;43(6):1085–93.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Huberty et al. Pilot and Feasibility Studies  (2018) 4:12 Page 16 of 16
